145 related articles for article (PubMed ID: 36959194)
1. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
Uraki R; Iida S; Halfmann PJ; Yamayoshi S; Hirata Y; Iwatsuki-Horimoto K; Kiso M; Ito M; Furusawa Y; Ueki H; Sakai-Tagawa Y; Kuroda M; Maemura T; Kim T; Mine S; Iwamoto N; Li R; Liu Y; Larson D; Fukushi S; Watanabe S; Maeda K; Wang Z; Ohmagari N; Theiler J; Fischer W; Korber B; Imai M; Suzuki T; Kawaoka Y
Nat Commun; 2023 Mar; 14(1):1620. PubMed ID: 36959194
[TBL] [Abstract][Full Text] [Related]
2. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.
Rissmann M; Noack D; van Riel D; Schmitz KS; de Vries RD; van Run P; Lamers MM; Geurts van Kessel CH; Koopmans MPG; Fouchier RAM; Kuiken T; Haagmans BL; Rockx B
Emerg Microbes Infect; 2022 Dec; 11(1):1778-1786. PubMed ID: 35787236
[TBL] [Abstract][Full Text] [Related]
5. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
Uraki R; Halfmann PJ; Iida S; Yamayoshi S; Furusawa Y; Kiso M; Ito M; Iwatsuki-Horimoto K; Mine S; Kuroda M; Maemura T; Sakai-Tagawa Y; Ueki H; Li R; Liu Y; Larson D; Fukushi S; Watanabe S; Maeda K; Pekosz A; Kandeil A; Webby RJ; Wang Z; Imai M; Suzuki T; Kawaoka Y
Nature; 2022 Dec; 612(7940):540-545. PubMed ID: 36323336
[TBL] [Abstract][Full Text] [Related]
6. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
[TBL] [Abstract][Full Text] [Related]
7. Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters.
Su W; Choy KT; Gu H; Sia SF; Cheng KM; Nizami SIN; Krishnan P; Ng YM; Chang LDJ; Liu Y; Cheng SMS; Peiris M; Poon LLM; Nicholls JM; Yen HL
J Infect Dis; 2023 May; 227(10):1143-1152. PubMed ID: 35776136
[TBL] [Abstract][Full Text] [Related]
8. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.
Yuan L; Zhu H; Chen P; Zhou M; Ma J; Liu X; Wu K; Chen R; Liu Q; Yu H; Li L; Wang J; Zhang Y; Ge S; Yuan Q; Tang Q; Cheng T; Guan Y; Xia N
Cell Mol Immunol; 2022 Dec; 19(12):1392-1399. PubMed ID: 36258005
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters.
Abdelnabi R; Lassaunière R; Maes P; Weynand B; Neyts J
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257822
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters.
Uraki R; Kiso M; Imai M; Yamayoshi S; Ito M; Fujisaki S; Takashita E; Ujie M; Furusawa Y; Yasuhara A; Iwatsuki-Horimoto K; Sakai-Tagawa Y; Watanabe S; Hasegawa H; Kawaoka Y
Nat Microbiol; 2022 Aug; 7(8):1252-1258. PubMed ID: 35705860
[TBL] [Abstract][Full Text] [Related]
12. [Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae:
Tuyskanova MS; Zhugunissov KD; Ozaslan M; Myrzakhmetova BS; Kutumbetov LB
Vopr Virusol; 2023 Dec; 68(6):513-525. PubMed ID: 38156567
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.
Machado RRG; Walker JL; Scharton D; Rafael GH; Mitchell BM; Reyna RA; de Souza WM; Liu J; Walker DH; Plante JA; Plante KS; Weaver SC
Nat Commun; 2023 Jul; 14(1):4260. PubMed ID: 37460536
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
[No Abstract] [Full Text] [Related]
15. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
[TBL] [Abstract][Full Text] [Related]
16. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters.
Halfmann PJ; Uraki R; Kuroda M; Iwatsuki-Horimoto K; Yamayoshi S; Ito M; Kawaoka Y
EBioMedicine; 2023 Jul; 93():104677. PubMed ID: 37352827
[TBL] [Abstract][Full Text] [Related]
17. Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.
Ryan KA; Bewley KR; Watson RJ; Burton C; Carnell O; Cavell BE; Challis A; Coombes NS; Davies ER; Edun-Huges J; Emery K; Fell R; Fotheringham SA; Gooch KE; Gowan K; Handley A; Harris DJ; Hesp R; Hunter L; Humphreys R; Johnson R; Kennard C; Knott D; Lister S; Morley D; Ngabo D; Osman KL; Paterson J; Penn EJ; Pullan ST; Richards KS; Summers S; Thomas SR; Weldon T; Wiblin NR; Rayner EL; Vipond RT; Hallis B; Salguero FJ; Funnell SGP; Hall Y
PLoS Pathog; 2023 Apr; 19(4):e1011293. PubMed ID: 37014911
[TBL] [Abstract][Full Text] [Related]
18. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.
Tamura T; Yamasoba D; Oda Y; Ito J; Kamasaki T; Nao N; Hashimoto R; Fujioka Y; Suzuki R; Wang L; Ito H; Kashima Y; Kimura I; Kishimoto M; Tsuda M; Sawa H; Yoshimatsu K; Yamamoto Y; Nagamoto T; Kanamune J; Suzuki Y; Ohba Y; ; Yokota I; Matsuno K; Takayama K; Tanaka S; Sato K; Fukuhara T
Commun Biol; 2023 Jul; 6(1):772. PubMed ID: 37488344
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
[TBL] [Abstract][Full Text] [Related]
20. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
